Skip to content

Author

Shruthi Ramesh

We have 1 of 4 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

A first-in-human study of CAL101, a monoclonal antibody targeting S100A4.

AIMS S100A4 is a damage-associated molecular pattern protein that amplifies pro-inflammatory and pro-fibrotic signalling. CAL101 is a first-in-class humanized monoclonal antibody that neutralizes S100A4. This first-in-human study evaluated safety, pharmacokinetics (PK), immunogenicity and exploratory pharmacodynamics (...

Jonas Hallén, S. Vetrhus, M. Sørgaard et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.